There is evidence that Beclin-1 (BECN1) acts as a suppressor of cancer and is involved in improving autophagy with lysosomal degradation; its expression levels are reduced in mammary carcinomas, particularly TNBC (171, 172). Here, BECN1 is linked to cancer.